POLR2A

  • 1 lab in 1 country
  • Funders: Chinese Academy of Medical Sciences and 4 more
  • Animals1
  • Cells3

Effects

3

p53–p21 pathway

downin human cells1

1 study
  1. POLR2A inhibits p53–p21 pathway in human cells.

    “activation of the p53/p21 pathway upon POLR2A knockdown”

    CellsPOLR2A knockdown

    LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis

    Cell death & disease28 Mar 2026

More on p53–p21 pathway

Senescent phenotype

downin human cells1

1 study
  1. POLR2A decreases senescent phenotype in human cells.

    “activating endogenous POLR2A expression in senescent cells using CRISPRa technology alleviated the senescent phenotype”

    CellsCRISPRa activation in senescent cells

    LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis

    Cell death & disease28 Mar 2026

Cellular senescence

downin human cells1

1 study
  1. POLR2A prevents cellular senescence in human cells.

    “Whereas its depletion dramatically induced cellular senescence”

    Cellsknockdown

    LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis

    Cell death & disease28 Mar 2026

More on Cellular senescence

Upstream

1

LMO7

downin human cells1

1 study
  1. LMO7 decreases POLR2A in human cells.

    “E3 ligase LMO7 was recruited to POLR2A to promote the ubiquitination and proteasomal degradation of POLR2A”

    Cellscellular senescence

    LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis

    Cell death & disease28 Mar 2026

More on LMO7

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 1Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 04 in 12 months